Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-023491

Chief Tech. Operations Officer sold 1,500 shares at $39.96 ($59,940)

  • Chief Tech. Operations Officer acquired 1,500 shares (option exercise)
  • Chief Tech. Operations Officer gave up 648 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Newell Joe · Chief Tech. Operations Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2019-04-01 Exercise or conversion : show line 1 in the form +1,500 $20.40 $30,600 63,646 D
2019-04-01 Sale : show line 2 in the form −1,500 $39.96 $59,940 62,146 D
2019-04-03 Shares withheld for taxes : show line 3 in the form −648 $41.04 $26,594 61,498 D
Open-market sales · 1,500 sh · avg $39.96 · $59,940

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-04-01 Exercise or conversion : show line 4 in the form Employee Stock Option (Right to Buy) −1,500 66,500 D
Loading xslF345X03/doc4.xml…